Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy

Bone Marrow Transplant. 2018 Jul;53(7):913-917. doi: 10.1038/s41409-017-0085-1. Epub 2018 Jan 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Genetic Therapy / methods*
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukodystrophy, Metachromatic / drug therapy*
  • Leukodystrophy, Metachromatic / pathology
  • Leukodystrophy, Metachromatic / therapy*
  • Male
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Polydeoxyribonucleotides / pharmacology
  • Polydeoxyribonucleotides / therapeutic use*
  • Transplantation Conditioning / methods*
  • Twins

Substances

  • Platelet Aggregation Inhibitors
  • Polydeoxyribonucleotides
  • defibrotide